
BioTech Nation ... with Dr. Moira Gunn
Moira GunnAudio
- Format:
- Podcast
- New episodes:
- Weekly
- Typical length:
- about 20 minutes
- Latest episode:
About this show
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
Covers: biotechnology, drug development, pharmaceutical industry, entrepreneurship, cancer treatment, artificial intelligence, chemistry, gout treatment
Show details and episodes come from the publisher's public feed at feeds.transistor.fm. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
BioTech Nation is an interview podcast, hosted by Moira Gunn, that explains science and biotech topics without requiring a science background. Recent episodes cover chemistry in everyday life, engineering microbes as fertilizer alternatives, and an early intervention treatment for heart attacks.
Cosmos
Similar in subject
- Chemistry World Podcast
Both cover: cancer treatment, chemistry - Approved
Both cover: drug development, biotechnology - BiotechTV - News
Both cover: pharmaceutical industry, biotechnology
Similar shows
Explore more
Episodes
Chemistry All Around Us...Dr. Ijeoma Uchegbu, Author, "Chain Reaction"
· 19 min
On this week's BioTech Nation, Moira speaks with Dr. Ijeoma Uchegbu, President of Wolfson College at the University of Cambridge, and Co-Founder & Chief Scientific Officer of Nanomerics, about how chemistry is all around us, all the time. Her book, "Chain Reaction: How Chemistry Shapes Us and Our World" delves into the chemical bonds and reactions that make up life as we know it.
Not rated yetEngineering the Future of Fertilizer...Dr. Tim Schnabel, Founder & CEO, Switch Bioworks
· 28 min
On this episode of Biotech Nation, Dr. Tim Schnabel talks about how Switch Bioworks aims to revolutionize the fertilizer industry by engineering special microbes in place of chemical fertilizers. With a biotech approach, they hope to reduce the cost and environmental impact of industrial fertilizers, and they're already working with the USDA and EPA on trials.
Not rated yet2005 Interview with Elizabeth Holmes, Founder & Former CEO of Theranos
· 20 min
On this episode of BioTech Nation, we look back at the first on-record interview with Theranos founder Elizabeth Holmes, recorded at KQED studios in 2005. At the time of the interview, Holmes was just 21 years old, and her company had already received almost $6 million in funding from investors. Now, over two decades have passed, and Elizabeth Holmes is serving time in prison for fraud. Revisiting the interview today, what can it tell us about where things went wrong?
Not rated yetRedefining Early Intervention for Heart Attacks...Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics
· 20 min
On this episode of BioTech Nation... Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms.
Not rated yetAI-Powered Biology...Dr. Shana Kelley, President of Bioengineering & Head of Biohub Chicago
· 25 min
This week on BioTech Nation, what is AI-Powered Biology? Dr. Shana Kelley, President of Bioengineering and Head of Biohub, Chicago for the Chan-Zuckerberg Initiative, discusses how AI can be used to accelerate research, interpret data, and transform how new discoveries are made.
Not rated yetImproving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals
· 19 min
This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several million people, but the approval process in the US has had to start back at square one. We look at why that is, and how LB is working on it.
Not rated yetFrom Film to Biotech...Toshi Iida, Chairman, FUJIFILM Biotechnologies
· 16 min
When you think of FUJIFILM, you might be picturing rolls of camera film...but it turns out that's not all they've been working on. FUJIFILM Biotechnologies Chairman Toshi Iida joins to share more about how they're innovating in the world of biotech.
Not rated yetReengineering Chemotherapy for Solid Tumors...Lew Bender, Founder, President & CEO, Intensity Therapeutics
· 18 min
What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.
Not rated yetA New Path Forward for Cell Therapy...Jeff Liter, Founder & CEO, Luminary Therapeutics
· 7 min
This week on BioTech Nation, Jeff Liter of Luminary Therapeutics shares how his team is taking a new approach to advanced cell therapy, in the hopes of making it more accessible and affordable. Rather than formulating a custom treatment using a patient's own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.
Not rated yetPaving the Way for Miracle Drugs...Barry Werth, Author, "The Age of Cures"
· 40 min
On this episode of Biotech Nation...the story of how the United States' pharmaceutical industry came to be, and the people behind it all. Barry Werth joins Moira to discuss his new book, “The Age of Cures: How American Scientists Saved Your Life", about a handful of individuals who revolutionized research and helped build the drug development ecosystem we have today.
Not rated yetA Different Approach to Treating Gout...Dr. James Mackay, Co-Founder, CEO, & President, Crystalys Therapeutics
· 14 min
On this episode of BioTech Nation...Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the treatment of gout - a disease that affects more than 13 million people in the United States alone. Dr. Mackay debunks some common misconceptions surrounding the disease, and explains what Crystalys is doing to change the way doctors treat gout going forward.
Not rated yetThe Potential of Peptide Drugs...Dr. Karsten Eastman, Co-Founder & CEO, Sethera Therapeutics
· 20 min
You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance peptides to make new medicines. Their plan: to develop a drug using enhanced peptides for Triple-Negative Breast Cancer... and they've already received funding.
Not rated yetInjectable Ice for Chronic Pain? Sameer Sabir, Co-Founder & CEO, Brixton Biosciences
· 13 min
This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.
Not rated yetHealing Hard-to-treat Wounds Faster?? Dr. Ned Swanson, Co-Founder, President & Chief Medical Officer, Polarity Bio
· 14 min
Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it's twice as effective as the current treatment for diabetic foot ulcers.
Not rated yetStem Cell Therapy for Congenital Heart Defects...Dr. Joshua Hare, Co-Founder & CSO, Longeveron
· 23 min
Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, we hear Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talk about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.
Not rated yetManaging Pain While Fighting Cancer...Dr. Lorin Johnson, CSO, Glycyx Therapeutics
· 16 min
This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.
Not rated yetA New Kind of Flu Shot...Dr. Jeff Stein, President & CEO, Cidara Therapeutics
· 18 min
This week on BioTech Nation, Dr. Jeff Stein, President & CEO of Cidara Therapeutics, brings up promising news about a new approach to flu shots.
Not rated yetA Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
· 24 min
On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a discovery made over two decades ago started it all. Now, with a new drug entering Phase II human trials for Glioblastoma treatment, that discovery could mean a pathway to treating aggressive cancers...
Not rated yetInsulin-Producing Cells...with no Immunosuppressants?? Dr. Steve Harr, Sana Biotechnology
· 14 min
This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without the need for immunosuppressant drugs.
Not rated yetLooking Forward: Biotech in the Balance? Dr. Jeremy Levin, Bioentrepreneur & Former Chair, BIO
· 48 min
On this episode of BioTech Nation...The Biotech landscape is ever-evolving - but where are we headed?? Dr. Jeremy Levin, Physician, Bioentrepreneur, and Former Chair of BIO, joins Moira to talk about the future of Biotech from the front lines of the industry - from understanding the global Bioeconomy, to preparing for the next pandemic, and how government policy is impacting innovation. His book is, "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust".
Not rated yet